Learn how to maintain long-term health when switching from brand-name to generic medications, including risks of bioequivalence and strategies for NTI drugs.
Quality by Design (QbD) has transformed generic drug development by shifting from end-product testing to science-based process control. Learn how FDA-mandated QbD improves approval rates, cuts review times, and enables flexible manufacturing through design spaces and real-time monitoring.